W e would like to thank Dr. Ata and colleagues for their interest in our recent article [5] that investigates the effect of ultrasound guidance on skin contamination at injection sites. Their response highlights the variety of techniques with which musculoskeletal injections are performed, particularly in the presence of ultrasound guidance. This has particular relevance when considering the prevention of iatrogenic infection, as even in the absence of ultrasound guidance, there is marked variability amongst practitioners in the antiseptic precautions taken. To this end, Charalambous et al. [1] reported that more than half of practitioners performing injections do not wear gloves and few isolate the injection field with sterile towels. To our knowledge, there is no similar report that summarizes antiseptic practices taken in the presence of ultrasound guidance. Although such a study would be useful, it is our own experience that many practitioners have dissimilar techniques with varying levels of precautionary methods taken to prevent contamination.
The indirect technique of ultrasound guidance, in which the relevant anatomy is visualized and then the probe removed prior to needle introduction, mitigates the potential for contamination of the injection site, as the area can be disinfected after probe removal but prior to injection. The direct technique, however, requires the probe to be in constant, close proximity to the needle and thereby increases the likelihood of contamination of the injection site with transmission gel. This technique is commonly reported in the literature and most popular in our experience [2, 4] . Although more challenging, this direct approach also allows for recording of images that demonstrates the location of the needle in the intended structure, which is often needed or at least helpful for appropriate procedure coding [3] .
The findings of our study are most salient to establishing safe practices for preventing contamination when using the direct approach and support using a disinfected probe and sterile ultrasound transmission gel, and perhaps most importantly, disinfecting a large skin area that includes surfaces where the probe will be placed in addition to the immediate injection site.
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